NOX4 inhibition has been shown to be anti-fibrotic in mouse models of the liver and pulmonary fibrosis [11,12] but inactive in kidney fibrosis, while the role of NOX4 has recently been challenged in TGF-β1-induced skin myofibroblast differentiation [13]. Here, NOX4 is linked to pulmonary fibrosis.